Published in J Cell Biol on October 04, 1999
The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J (2000) 9.51
Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol (2005) 3.48
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development (2005) 2.73
Hormonal and local control of mammary branching morphogenesis. Differentiation (2006) 2.60
The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med (2014) 2.48
The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol (2004) 2.41
Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci U S A (2003) 2.38
CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev (2002) 2.35
Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron (2008) 2.27
Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol (2001) 2.05
Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol Cell Biol (2001) 1.80
Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol Cell Biol (2004) 1.78
Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling. Breast Cancer Res (2004) 1.61
Extracellular domains drive homo- but not hetero-dimerization of erbB receptors. EMBO J (2000) 1.55
Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors. Carcinogenesis (2010) 1.42
Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases. Breast Cancer Res (2000) 1.37
ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo. Mol Cell Biol (2009) 1.28
The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Mol Biol Cell (2006) 1.23
The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis. Cancer Res (2008) 1.23
ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. J Mammary Gland Biol Neoplasia (2008) 1.20
HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer. J Mammary Gland Biol Neoplasia (2008) 1.20
Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e. J Biol Chem (2011) 1.10
The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. J Cell Biol (2001) 1.10
Mammary gland growth factors: roles in normal development and in cancer. Cold Spring Harb Perspect Biol (2010) 1.08
Cell death or survival promoted by alternative isoforms of ErbB4. Mol Biol Cell (2010) 1.07
The ADAM17-amphiregulin-EGFR axis in mammary development and cancer. J Mammary Gland Biol Neoplasia (2008) 1.06
The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation. Mol Endocrinol (2007) 1.05
Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways. Genes Dev (2012) 1.04
Estrogen and progesterone are critical regulators of Stat5a expression in the mouse mammary gland. Endocrinology (2007) 1.02
Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer. Breast Cancer Res (2011) 1.01
ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis. Mol Biol Cell (2007) 1.00
Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells. Oncogene (2010) 0.99
Overexpression of miR-30b in the developing mouse mammary gland causes a lactation defect and delays involution. PLoS One (2012) 0.99
Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration. Sci Signal (2014) 0.98
Roles for neuregulins in human cancer. Clin Exp Metastasis (2004) 0.98
Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands. J Cell Biol (2003) 0.97
Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1. Mol Cell Biol (2006) 0.94
The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium. Mol Cancer (2010) 0.93
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens. FASEB J (2012) 0.93
Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines. Oncol Res (2006) 0.90
Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling. J Biol Chem (2012) 0.89
Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein. J Biol Chem (2012) 0.87
Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway. J Cell Physiol (2004) 0.85
Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways. Mol Cancer Res (2010) 0.84
Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation. Mol Endocrinol (2008) 0.81
Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake. Sci Signal (2015) 0.81
Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells. Mol Cancer Res (2014) 0.79
Prolactin signaling and Stat5: going their own separate ways? Breast Cancer Res (2002) 0.79
Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis. Breast Cancer Res (2014) 0.78
Biological function of nuclear receptor tyrosine kinase action. Cold Spring Harb Perspect Biol (2013) 0.78
Epithelial Xbp1 is required for cellular proliferation and differentiation during mammary gland development. Mol Cell Biol (2015) 0.77
Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland. J Biol Chem (2014) 0.77
In vivo evidence for epidermal growth factor receptor (EGFR)-mediated release of prolactin from the pituitary gland. J Biol Chem (2011) 0.77
Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model. Front Pharmacol (2016) 0.75
MicroRNA roles in signalling during lactation: an insight from differential expression, time course and pathway analyses of deep sequence data. Sci Rep (2017) 0.75
The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor Family. Front Cell Dev Biol (2016) 0.75
High expression of PTPN21 in B-cell non-Hodgkin's gastric lymphoma, a positive mediator of STAT5 activity. Blood Cancer J (2016) 0.75
CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy. PLoS Genet (2017) 0.75
Direct coupling of the HER4 intracellular domain (4ICD) and STAT5A signaling is required to induce mammary epithelial cell differentiation. Biochem Biophys Rep (2016) 0.75
Improved retroviral vectors for gene transfer and expression. Biotechniques (1989) 19.48
Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem (1995) 8.52
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell (1998) 5.92
Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev (1997) 5.57
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature (1995) 5.51
The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta (1994) 4.92
Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J (1994) 4.03
Specificity within the EGF family/ErbB receptor family signaling network. Bioessays (1998) 3.37
Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci U S A (1993) 3.36
Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J (1994) 3.32
The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett (1997) 3.23
The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol (1995) 3.09
Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development (1999) 2.89
Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ (1997) 2.63
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol (1986) 2.52
ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J Biol Chem (1999) 2.41
Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc Natl Acad Sci U S A (1991) 2.16
Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development (1999) 2.04
Expression of the ERBB3 gene product in breast cancer. Br J Cancer (1992) 2.01
Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell (1988) 2.00
A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc Natl Acad Sci U S A (1995) 1.95
Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol (1995) 1.91
Expression of c-erbB3 protein in primary breast carcinomas. Br J Cancer (1998) 1.88
Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol Endocrinol (1996) 1.86
Mouse whey acidic protein is a novel member of the family of 'four-disulfide core' proteins. Nucleic Acids Res (1982) 1.70
Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Dev Biol (1988) 1.60
Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ (1998) 1.57
Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J Cell Biol (1998) 1.56
Expression of multiple forms of the prolactin receptor in mouse liver. Mol Endocrinol (1989) 1.49
Mammary gland-specific nuclear factor is present in lactating rodent and bovine mammary tissue and composed of a single polypeptide of 89 kDa. J Biol Chem (1992) 1.42
Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol (1997) 1.42
Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol (1998) 1.41
Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci U S A (1991) 1.40
Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ (1996) 1.39
STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science (1999) 1.38
Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ (1998) 1.37
Growth factors in breast cancer. Endocr Rev (1995) 1.37
STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem (1996) 1.35
Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation. Oncogene (1999) 1.31
c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene (1998) 1.30
Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. Proc Natl Acad Sci U S A (1995) 1.29
Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. J Biol Chem (1998) 1.26
c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival. Histopathology (1994) 1.21
Prolactin signaling in mammary gland development. J Biol Chem (1997) 1.18
Expression of two forms of prolactin receptor in rat ovary and liver. Mol Endocrinol (1990) 1.17
Local effects of EGF, alpha-TGF, and EGF-like growth factors on lobuloalveolar development of the mouse mammary gland in vivo. J Cell Physiol (1987) 1.15
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. Am J Pathol (1996) 1.12
The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer. Breast Cancer Res Treat (1998) 1.11
Regulation of mammary gland factor/Stat5a during mammary gland development. Mol Endocrinol (1995) 1.11
Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differ (1996) 1.08
Prolactin-mediated gene activation in mammary epithelial cells. Curr Opin Genet Dev (1995) 1.05
Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction. J Biol Chem (1994) 1.04
Isolation and characterization of the mouse alpha-lactalbumin-encoding gene: interspecies comparison, tissue- and stage-specific expression. Gene (1992) 1.01
Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Implication for tumor biology and clinical behavior. Am J Clin Pathol (1994) 0.96
The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter. Mol Endocrinol (1997) 0.96
c-erbB-3 protein expression in ductal carcinoma in situ of the breast. Eur J Cancer (1997) 0.94
Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene (1996) 0.92
Cytokine-receptor complexes as chaperones for nuclear translocation of signal transducers. Biochem Biophys Res Commun (1998) 0.90
Corticosterone is required for the prolactin receptor gene expression in the late pregnant mouse mammary gland. Mol Cell Endocrinol (1997) 0.89
Comparative study on the phosphotyrosine motifs of different cytokine receptors involved in STAT5 activation. FEBS Lett (1996) 0.89
Prolactin receptor gene expression in rat mammary gland and liver during pregnancy and lactation. Endocrinology (1991) 0.85
EGF induces nuclear translocation of STAT2 without tyrosine phosphorylation in intestinal epithelial cells. Am J Physiol (1999) 0.83
Differential expression of the neu transgene in murine mammary tissues. Int J Oncol (1997) 0.82
Dramatic heterogeneity of transgene expression in the mammary gland of lactating mice: a model system to study the synthetic activity of mammary epithelial cells. J Histochem Cytochem (1995) 0.77
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature (1985) 6.23
Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A (1985) 5.93
Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci U S A (1992) 5.50
Spk1/Rad53 is regulated by Mec1-dependent protein phosphorylation in DNA replication and damage checkpoint pathways. Genes Dev (1996) 4.98
The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta (1994) 4.92
Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint. Science (1998) 4.59
Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol (1992) 3.90
Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science (1996) 3.70
Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev (1990) 3.65
Weaning from mechanical ventilation. Eur Respir J (2007) 3.59
Specificity within the EGF family/ErbB receptor family signaling network. Bioessays (1998) 3.37
The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell (1989) 3.24
New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax (2009) 3.21
The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol (1995) 3.09
Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem (1996) 3.01
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell (1985) 2.75
Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol (1997) 2.71
Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014. Euro Surveill (2014) 2.65
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol (1986) 2.52
Factors influencing alternative splice site utilization in vivo. Mol Cell Biol (1987) 2.39
Coronavirus multiplication strategy. I. Identification and characterization of virus-specified RNA. J Virol (1980) 2.30
Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature (1997) 2.03
Coronavirus multiplication strategy. II. Mapping the avian infectious bronchitis virus intracellular RNA species to the genome. J Virol (1980) 2.02
Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J (2004) 2.02
[Use of a lung function screening device for identifying patients at risk for COPD in general practice]. Pneumologie (2012) 2.01
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J (2008) 1.97
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer. Ann Oncol (2007) 1.90
Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene. Nature (1985) 1.88
Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant (2010) 1.87
Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene (1996) 1.78
Cathepsin K--a marker of macrophage differentiation? J Pathol (2001) 1.77
Experience with inhaled iloprost and bosentan in portopulmonary hypertension. Eur Respir J (2007) 1.75
A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum Mol Genet (1999) 1.72
Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J (2005) 1.71
Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc Natl Acad Sci U S A (1986) 1.69
CRB-65 predicts death from community-acquired pneumonia. J Intern Med (2006) 1.61
[Guidelines for diagnosis and treatment of asthma patients]. Pneumologie (2006) 1.59
Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor. Mol Cell Biol (1986) 1.57
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis (2008) 1.55
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur Respir J (2009) 1.54
SPK1 is an essential S-phase-specific gene of Saccharomyces cerevisiae that encodes a nuclear serine/threonine/tyrosine kinase. Mol Cell Biol (1993) 1.54
Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation. Oncogene (1997) 1.52
[Management of a new influenza A/H1N1 virus pandemic within the hospital: statement of the German Society of Pneumology]. Pneumologie (2009) 1.51
Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant (2013) 1.49
A role for DNA primase in coupling DNA replication to DNA damage response. EMBO J (1997) 1.48
Cathepsin-regulated apoptosis. Apoptosis (2006) 1.47
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer. J Clin Oncol (2000) 1.47
[Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance]. Dtsch Med Wochenschr (2008) 1.45
Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther (2000) 1.44
Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM (2003) 1.44
Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature (1997) 1.43
Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat. Regul Pept (2001) 1.42
Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ (1996) 1.39
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J (2010) 1.38
STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science (1999) 1.38
IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res (1998) 1.38
A subdomain in the transmembrane domain is necessary for p185neu* activation. EMBO J (1992) 1.34
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J (2007) 1.34
Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol Cell Biol (2000) 1.33
Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation. Oncogene (1999) 1.31
Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science (1987) 1.30
Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis. Am J Physiol (1999) 1.30
Mutations in SPK1/RAD53 that specifically abolish checkpoint but not growth-related functions. Curr Genet (1997) 1.30
Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface. Mol Cell Biol (1998) 1.30
The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J (2011) 1.28
Coronavirus multiplication: locations of genes for virion proteins on the avian infectious bronchitis virus genome. J Virol (1984) 1.28
The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. J Biol Chem (1996) 1.28
Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2. J Biol Chem (1998) 1.26
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur Respir J (2009) 1.24
[Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin]. Pneumologie (2007) 1.23
The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis (2014) 1.22
Coronavirus proteins: biogenesis of avian infectious bronchitis virus virion proteins. J Virol (1982) 1.22
Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Curr Med Res Opin (2004) 1.21
The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema. Intensive Care Med (1999) 1.21
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells. Br J Cancer (2009) 1.18
Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor. Cancer Res (1995) 1.17
Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins. J Virol (1982) 1.17
Development and evaluation of an implementation strategy for the German guideline on community-acquired pneumonia. Qual Saf Health Care (2010) 1.16
Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant (2009) 1.15
Effects of propofol and desflurane anaesthesia on the alveolar inflammatory response to one-lung ventilation. Br J Anaesth (2007) 1.13
Suppression of pulmonary innate host defence in smokers. Thorax (2008) 1.12
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. Am J Pathol (1996) 1.12
Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial. Eur J Cancer (2002) 1.11
The burden of pneumococcal pneumonia - experience of the German competence network CAPNETZ. Pneumologie (2012) 1.10
Use of G-protein fusions to monitor integral membrane protein-protein interactions in yeast. Nat Biotechnol (2000) 1.10
[SARS--Severe Acute Respiratory syndrome]. Pneumologie (2003) 1.09
Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J Biol Chem (1997) 1.08
Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Respir J (2002) 1.08
[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study]. Dtsch Med Wochenschr (2008) 1.08
Tyrosine phosphorylation is an early and specific event involved in primary keratinocyte differentiation. Mol Cell Biol (1990) 1.07
Focal adhesion kinase activates Stat1 in integrin-mediated cell migration and adhesion. J Biol Chem (2001) 1.07
Are metallic stents really safe? A long-term analysis in lung transplant recipients. Eur Respir J (2009) 1.06
Promoter-dependent synergy between glucocorticoid receptor and Stat5 in the activation of beta-casein gene transcription. J Biol Chem (1997) 1.04
Expression of cathepsin K in lung epithelial cells. Am J Respir Cell Mol Biol (1999) 1.04
c-myc is required for osteoclast differentiation. J Bone Miner Res (2002) 1.03
Active signaling by Neu in transgenic mice. Oncogene (1998) 1.03
Mesalazine alveolitis. Lancet (1991) 1.02